These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Urinary delta-aminolevulinic acid as a biological indicator throughout penicillamine therapy in lead intoxication.
    Author: Molina-Ballesteros G, Zuñiga-Charles MA, Sanchez-Anzaldo FJ, Gonzalez-Ramirez JD.
    Journal: Arch Environ Health; 1978; 33(6):308-13. PubMed ID: 736614.
    Abstract:
    A group of 121 patients with occupational lead exposure was studied. Saturnism was confirmed in 42 of them. Patients were given D-penicillamine in doses of 0.75 and 1.5 g/day. Urinary delta-aminolevulinic acid was selected as a toxicity biological indicator; its concentrations were quantified daily during therapy. Urinary delta-aminolevulinic acid is considered a good biological indicator throughout penicillamine therapy and also in the detection of lead intoxication. Likewise, the chelating test is considered an excellent method to confirm the diagnosis of lead poisoning.
    [Abstract] [Full Text] [Related] [New Search]